Literature DB >> 27732982

Is Extracorporeal Shock Wave Lithotripsy Really Safe in Long-Term Follow-Up? A Nationwide Retrospective 6-Year Age-Matched Non-Randomized Study.

Yen-Man Lu1, Tsu-Ming Chien, Yii-Her Chou, Wen-Jeng Wu, Chun-Nung Huang.   

Abstract

INTRODUCTION: Shock wave lithotripsy (SWL) is widely used. However, several studies have reported increased blood pressure immediately after SWL. Until now, the association between SWL and new-onset hypertension has been a topic of discussion. This study is aimed at determining whether SWL leads to new-onset hypertension.
METHODS: Data were sourced from the Longitudinal Health Insurance Database 2000 of Taiwan, Republic of China, which was compiled from 1996 to 2010 using National Health Insurance data. Patients who had undergone SWL were compared with controls that were matched for age, sex, obesity, diabetes mellitus, and hyperlipidemia.
RESULTS: Patients who had undergone SWL had a higher incidence of new-onset hypertension compared to the control groups. Furthermore, new hypertension developed faster in the SWL group.
CONCLUSIONS: The results of this study demonstrated that an association exists between nephrolithiasis patients who were treated with SWL and subsequent hypertension diagnosis. Patients who undergo SWL may need regular follow-up of blood pressure.
© 2016 S. Karger AG, Basel.

Entities:  

Keywords:  Hypertension; Long-term follow-up; Nephrolithiasis; Shock wave lithotripsy

Mesh:

Year:  2016        PMID: 27732982     DOI: 10.1159/000451005

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  1 in total

1.  Association between renal urolithiasis after extracorporeal shock wave lithotripsy therapy and new-onset hypertension: an updated meta-analysis.

Authors:  Qiao Wu; Rui Liang; Yi Huang; Chunlin Tan; Guangqiang Zhu; Yanjun Chen; Liang Cao; Bing Zou; Xin Li; Haiyun Wang; Xiaojun Wang; Tielong Tang; Tao Wu
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.